Does GILTERITINIB Cause Off label use? 334 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 334 reports of Off label use have been filed in association with GILTERITINIB (Xospata). This represents 9.1% of all adverse event reports for GILTERITINIB.
334
Reports of Off label use with GILTERITINIB
9.1%
of all GILTERITINIB reports
79
Deaths
104
Hospitalizations
How Dangerous Is Off label use From GILTERITINIB?
Of the 334 reports, 79 (23.7%) resulted in death, 104 (31.1%) required hospitalization, and 19 (5.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GILTERITINIB. However, 334 reports have been filed with the FAERS database.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
Neutrophil count decreased (162)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which GILTERITINIB Alternatives Have Lower Off label use Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB